Michael Hehenberger

Dr. Hehenberger has earned advanced degrees in physics (TU Vienna) and quantum chemistry (Uppsala University). His ten years of academic research also included the position of Visiting Associate Professor at the University of Florida (Gainesville). In 1985 he joined IBM Sweden to work on academic partnerships in computational chemistry, structural engineering, and high performance computing. Throughout his IBM career which took him to Paris, San Jose (California), and New York, he has led collaborations with academic and industrial life sciences organizations. The partnerships were focused on molecular biology, information based medicine, bio-pharmaceutical research, unstructured data analytics, genomics and nanomedicine. In 2013 he started the HM NanoMed Partnership where he is focused on writing books, co-organizing conferences and pursuing nanomedical and genomic research topics.

His first book “Nanomedicine: Science, Business, and Impact” covers both the underlying science and the steps needed to take a new biomedical breakthrough all the way from concept to patient benefit. Together with BGI, he has recently published “Our Animal Connection”, a book that is focused on benefits derived from the study of capabilities that evolved in other living organisms with regard to medical research, human health and performance. The second edition includes a chapter on infectious diseases (such as COVID) that frequently are transmitted to humans by animals.